Omeros Posts 2,652 Percent Sales Jump
Omeros ( NASDAQ:OMER ) , a biopharmaceutical company focused on developing treatments for rare diseases and immune-related conditions, released its second quarter results on August 14, 2025. The headline news from the release was a significant revenue beat, as Omeros reported GAAP revenue of $8.6 ...
Market Barriers Continue to Challenge PNH Treatment Optimization Despite Emerging Options, According to Spherix Global Insights
EXTON, PA, July 08, 2025 ( GLOBE NEWSWIRE ) -- Paroxysmal nocturnal hemoglobinuria ( PNH ) is a rare, chronic blood disorder that can affect individuals of any age, race, or gender, though it is most commonly diagnosed in adults in their 30s and 40s.
Omeros Analyst Sees $1B Potential For Drug Before FDA Decision - Omeros ( NASDAQ:OMER )
According to the analyst, Omeros holds significant long-term value potential due to its expansive rare disease pipeline. Omeros refocuses pipeline and balance sheet to support Narsoplimab launch and long-term growth. Get access to the leaderboards pointing to tomorrow's biggest stock movers.
This Domino's Pizza Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Tuesday - Dynatrace ( NYSE:DT ) , Domino's Pizza ( NASDAQ:DPZ )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Eric Heath initiated coverage on Dynatrace, Inc.
Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros ( OMER )
Omeros (OMER) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Agilon Health ( NYSE:AGL ) , ANI Pharmaceuticals ( NASDAQ:ANIP )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Bausch & Lomb ( NYSE:BLCO ) , AleAnna ( NASDAQ:ANNA )
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Monday. Shares of Eagle Financial Services, Inc. EFSI fell sharply in today's pre-market trading after the company released financial results for the first quarter.
Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight - Omeros ( NASDAQ:OMER )
OncotoX-AML showed superior survival benefit in preclinical studies vs. venetoclax and azacitidine. Therapy kills AML blasts and stem cells at low doses without neutropenia or blood toxicity. Feel unsure about the market's next move?
Bitcoin Falls To $85K, Altcoins Drop Ahead Of Inflation Data; Trump's Tariffs May Raise $800B, But Risks Loom; Tesla Faces EV Incentive Cuts In UK After Canada - Top Headlines While The U.S. Slept
Galaxy Digital To Pay $200 Million In Terra-LUNA Settlement With New York Attorney General Bitcoin Down To $85,000, Ethereum, XRP Slide 5% Before Key Inflation Data Trump's SEC Pick Paul Atkins Says His 'Top Priority' Will Be 'Rational' Crypto Regulations, Marking Shift From Gary Gensler's Approach
Top Wall Street Forecasters Revamp Omeros Price Expectations Ahead Of Q4 Earnings - Omeros ( NASDAQ:OMER )
Omeros Corporation OMER will release its fourth-quarter financial results after the closing bell on Monday, March 31. Analysts expect the Seattle, Washington-based company to report quarterly loss at 78 cents per share, versus a year-ago loss of 69 cents per share, according to data from Benzinga ...
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Incyte ( NASDAQ:INCY ) , Affirm Holdings ( NASDAQ:AFRM )
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday. Shares of Incyte Corporation INCY fell sharply in today's pre-market trading after reporting topline results from two Phase 3 clinical trials of Povorcitinib in patients with Hidradenitis ...
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Aspira Womens Health ( NASDAQ:AWH ) , Aclarion ( NASDAQ:ACON )
Shares of Precision BioSciences, Inc. DTIL rose sharply in today's pre-market trading. Precision BioSciences reported clearance of investigational new drug application by the U.S. FDA for first-in-class PBGENE-HBV designed to eliminate root cause of chronic hepatitis B.
Iovance Biotherapeutics Shares Fell Today: What's Going On? - Iovance Biotherapeutics ( NASDAQ:IOVA )
Iovance Biotherapeutics shares fell 6.41% after appointing Dan Kirby as Chief Commercial Officer, signaling investor concerns. The decline reflects skepticism about the company's growth trajectory, competitive landscape, and potential challenges in launching its TIL.
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer - Iovance Biotherapeutics ( NASDAQ:IOVA )
SAN CARLOS, Calif., Feb. 10, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc.
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Omeros ( NASDAQ:OMER ) , NCR Atleos ( NYSE:NATL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Scotiabank analyst Sung Ji Nam initiated coverage on Thermo Fisher Scientific Inc.
Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline - Snow Lake Resources ( NASDAQ:LITM ) , Bio-Path Hldgs ( NASDAQ:BPTH )
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.55% to 42,557.62 while the NASDAQ rose 0.52% to 19,492.93. The S&P 500 also rose, gaining, 0.46% to 5,899.14. Utilities shares rose by 1.3% on Thursday.
Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges - Omeros ( NASDAQ:OMER )
On Thursday, Omeros Corporation OMER announced that an independent statistical group has completed the primary statistical analysis agreed with the FDA for narsoplimab.
Gold Falls Sharply, Lamb Weston Shares Plunge - Snow Lake Resources ( NASDAQ:LITM ) , Bio-Path Hldgs ( NASDAQ:BPTH )
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.4% on Thursday. The Dow traded up 0.39% to 42,493.51 while the NASDAQ rose 0.39% to 19,468.70. The S&P 500 also rose, gaining, 0.38% to 5,894.42. Utilities shares rose by 1.1% on Thursday.
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday - Darden Restaurants ( NYSE:DRI ) , Accenture ( NYSE:ACN )
U.S. stocks were higher, with the Dow Jones index gaining over 150 points on Thursday. Shares of Accenture plc ACN rose sharply in today's session after the company reported better-than-expected first-quarter financial results and raised FY25 revenue growth outlook.
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday - Atkore ( NYSE:ATKR ) , Carpenter Tech ( NYSE:CRS )
U.S. stocks were mixed, with the Dow Jones index gaining more than 150 points on Friday. Shares of Natural Grocers by Vitamin Cottage, Inc. NGVC rose sharply during Friday's session following quarterly results.
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session - NVIDIA ( NASDAQ:NVDA )
U.S. stock futures were mixed this morning, with the Dow futures falling more than 100 points on Monday. Shares of Neurogene Inc. NGNE fell sharply in today's pre-market trading after the company announced it brought its high-dose gene therapy trial to a halt after a serious adverse event in a ...
Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment
EXTON, PA, June 13, 2024 ( GLOBE NEWSWIRE ) -- Complement 3 glomerulopathy ( C3G ) is a rare kidney disease that presents significant challenges for both patients and nephrologists. Currently, there are no therapies specifically approved to treat this disease.
Omeros ( NASDAQ:OMER ) Cut to "Sell" at StockNews.com
Omeros ( NASDAQ:OMER - Get Free Report ) was downgraded by StockNews.com from a "hold" rating to a "sell" rating in a research note issued to investors on Friday. Separately, Needham & Company LLC reissued a "hold" rating on shares of Omeros in a report on Thursday.
Crude Oil Moves Higher; Deere Cuts Profit Outlook - Deere ( NYSE:DE )
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.1% on Thursday. The Dow traded up 0.01% to 39,912.06 while the NASDAQ fell 0.10% to 16,726.17. The S&P 500 also fell, dropping, 0.04% to 5,306.04. Consumer staples shares rose by 1.7% on Thursday.
US Stocks Edge Higher; Initial Jobless Claims Fall - Omeros ( NASDAQ:OMER )
U.S. stocks traded slightly higher this morning on Thursday. Following the market opening Thursday, the Dow traded up 0.01% to 39,913.23 while the NASDAQ rose 0.06% to 16,753.07. The S&P 500 also rose, gaining, 0.06% to 5,311.26. Consumer staples shares rose by 1.1% on Thursday.
Omeros ( NASDAQ:OMER ) Upgraded to "Hold" at StockNews.com
Omeros ( NASDAQ:OMER - Get Free Report ) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating in a research report issued to clients and investors on Wednesday. OMER stock opened at $3.05 on Wednesday. The firm has a 50 day moving average of $3.87 and a 200-day ...
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter - MSC Industrial Direct Co ( NYSE:MSM ) , Natural Gas Services Gr ( NYSE:NGS )
The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, while the S&P 500 surged to a new all-time high and also recorded its best first-quarter performance in five years.
Omeros ( NASDAQ:OMER ) Downgraded by StockNews.com to Sell
StockNews.com lowered shares of Omeros ( NASDAQ:OMER - Free Report ) from a hold rating to a sell rating in a research note released on Tuesday morning. OMER opened at $3.46 on Tuesday. The company has a market cap of $217.53 million, a PE ratio of 10.81 and a beta of 1.38.
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday - Tesla ( NASDAQ:TSLA ) , New York Community ( NYSE:NYCB )
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. TSLA fell during Monday's session after the company reportedly saw a decline in February China sales.
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results
- 82% royalty income growth over prior year period underscores transformative year - - Announcing 2024 royalty income guidance of US$153 to US$155 million, excluding milestone income and any new transactions - - Increasing quarterly cash distribution -
Omeros ( NASDAQ:OMER ) Upgraded to Hold by StockNews.com
Omeros ( NASDAQ:OMER - Get Free Report ) was upgraded by equities researchers at StockNews.com from a "sell" rating to a "hold" rating in a research note issued on Sunday. Separately, Cantor Fitzgerald downgraded shares of Omeros from an "overweight" rating to a "neutral" rating in a research ...
Brian's Big Idea on Biotech
A look at drugs for drug addiction and the biotech space.
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs - EyePoint Pharmaceuticals ( NASDAQ:EYPT ) , Altimmune ( NASDAQ:ALT )
As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices ...
Omeros ( NASDAQ:OMER ) Lowered to Sell at StockNews.com
StockNews.com lowered shares of Omeros ( NASDAQ:OMER - Free Report ) from a hold rating to a sell rating in a research report sent to investors on Tuesday. Separately, Cantor Fitzgerald downgraded shares of Omeros from an overweight rating to a neutral rating in a report on Friday, November 10th.
Insiders Buying Taysha Gene Therapies And 3 Other Stocks Under $2 - ATAI Life Sciences ( NASDAQ:ATAI ) , Gannett Co ( NYSE:GCI )
The Dow Jones closed higher by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Omeros ( NASDAQ:OMER ) Upgraded by StockNews.com to "Hold"
StockNews.com upgraded shares of Omeros ( NASDAQ:OMER - Free Report ) from a sell rating to a hold rating in a research note issued to investors on Monday. Separately, Cantor Fitzgerald reiterated a neutral rating on shares of Omeros in a research report on Friday.
vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer - vTv Therapeutics ( NASDAQ:VTVT )
HIGH POINT, N.C., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- vTv Therapeutics Inc. VTVT, a clinical stage biopharmaceutical company focused on the development of cadisegliatin ( TTP399 ) as an adjunctive therapy to insulin for the treatment of type 1 diabetes ( "T1D" ) , today announced the appointment ...
vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer
HIGH POINT, N.C., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- vTv Therapeutics Inc. ( Nasdaq: VTVT ) , a clinical stage biopharmaceutical company focused on the development of cadisegliatin ( TTP399 ) as an adjunctive therapy to insulin for the treatment of type 1 diabetes ( "T1D" ) , today announced ...
Crude Oil Moves Lower; Consolidated Communications Shares Jump - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Amphenol ( NYSE:APH )
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Monday. The Dow traded up 0.93% to 33,983.22 while the NASDAQ rose 1.31% to 13,582.67. The S&P 500 also rose, gaining, 1.11% to 4,375.72. Consumer discretionary shares climbed by 1.4% on Friday.
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Alignment Healthcare ( NASDAQ:ALHC )
MingZhu Logistics Holdings Limited YGMZ shares gained 64% to $0.7798 after gaining more than 10% on Friday. PCTEL, Inc. PCTI climbed 47.3% to $6.86. On Friday, Amphenol Corp APH inked a deal to acquire PCTEL for around $139.7 million. Almacenes Éxito S.A. EXTO shares rose 32.6% to $6.66.
Nasdaq Gains 1%; Charles Schwab Earnings Top Views - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Amphenol ( NYSE:APH )
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.02% to 34,012.79 while the NASDAQ rose 1% to 13,541.79. The S&P 500 also rose, gaining, 1.03% to 4,372.52. Consumer discretionary shares climbed by 1.4% on Friday.
Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Amphenol ( NYSE:APH )
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.72% to 33,913.22 while the NASDAQ rose 0.46% to 13,468.82. The S&P 500 also rose, gaining, 0.60% to 4,353.60. Energy shares climbed by 1.1% on Friday.
Why Omeros Corporation ( OMER ) Shares Are Nosediving - Omeros ( NASDAQ:OMER )
Omeros Corp OMER shares are trading lower by 47% to $1.20 during Monday's pre-market session. The company has provided an update on its Phase 3 trial ( ARTEMIS-IGAN ) evaluating narsoplimab for the treatment of IgA nephropathy, an immunologic disorder.
Omeros terminates kidney disease trial as therapy fails in late-stage study
Oct 16 ( Reuters ) - Omeros Corp ( OMER.O ) said on Monday it will discontinue a trial studying its experimental therapy to treat a type of kidney disease after it failed to meet the main goal of the late-stage study.
Binge-eating Disorder Treatment Market size is set to grow by USD 578.04 million from 2022 to 2027 | The increasing ... - PR Newswire
Binge-eating Disorder Treatment Market size is set to grow by USD 578.04 million from 2022 to 2027 | The increasing ... PR ...
StockNews.com Initiates Coverage on Omeros ( NASDAQ:OMER )
StockNews.com assumed coverage on shares of Omeros ( NASDAQ:OMER - Free Report ) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company's stock. Separately, Cantor Fitzgerald reissued an overweight rating on shares of Omeros in a ...
Omeros ( NASDAQ:OMER ) Coverage Initiated at StockNews.com
Analysts at StockNews.com began coverage on shares of Omeros ( NASDAQ:OMER - Get Free Report ) in a report issued on Sunday. The firm set a "sell" rating on the biopharmaceutical company's stock. Separately, Cantor Fitzgerald reiterated an "overweight" rating on shares of Omeros in a report on ...
Omeros ( NASDAQ:OMER ) Cut to "Sell" at StockNews.com
Omeros ( NASDAQ:OMER - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a "hold" rating to a "sell" rating in a report issued on Saturday. Separately, Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Omeros in a report on Monday, July 10th.
Omeros ( NASDAQ:OMER ) Stock Rating Upgraded by StockNews.com
Omeros ( NASDAQ:OMER - Get Free Report ) was upgraded by research analysts at StockNews.com from a "sell" rating to a "hold" rating in a report released on Friday. Separately, Cantor Fitzgerald reiterated an "overweight" rating on shares of Omeros in a report on Monday, July 10th.
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the ... PR ...
